Autopsy report · NCT00933348
Safety and Efficacy of the Fruit-based Product OPAL A for the Treatment of Chronic Venous and Pressure Ulcers
Cause of deathSlow enrollment
“Slow recruitment caused rethink on the study design”
Life of this trial
- Registered 6 months before it started.
- Suspended: paused, and may or may not restart.
- 30 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 2
- Sponsor
- Phoenix Eagle Company
- Sponsor type
- Industry
- Conditions
- Venous Ulcer; Pressure Ulcer
- Interventions
- OPAL A; Placebo
- Participants
- 30 (planned, not actual)
- Sites
- 1
- Countries
- Australia
Trials that died the same way
- SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic Encephalopathy
“Slow recruitment of study participants” - Calcium, Vitamin D and Metformin to Treat Insulin Resistance in Obese African American Adolescent Females
“Poor recruitment to the study” - Imaging Location of Hamstring Muscle Lesions in Sport and Relationships With Injury Mechanism.
“Reduced recruitment potential for study participants.” - Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis
“Not enough study participants, difficulties in recruitment” - Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor
“Study halted due to slow recruitment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.